Fingerprint
Dive into the research topics of 'Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation
Philip G. Thomas, Kenneth J. Woodside, Jacqueline A. Lappin, Smita Vaidya, Srinivasan Rajaraman, Kristene K. Gugliuzza
Research output: Contribution to journal › Article › peer-review
64
Scopus
citations